• #1080947
  • 606
  • Glaxo Smith Kline #58160081912

Shingrix® Shingles Vaccine 50 Years of Age and Older Zoster Vaccine Recombinant, Adjuvanted 50 mcg / 0.5 mL Injection Single Dose Vial Kit 1 Dose

SHINGRIX VACC, SDV 50MCG/0.5ML0.5ML

Features
  • SHINGRIX is a vaccine indicated for prevention of herpes zoster (shingles) in adults aged 50 years and older
  • SHINGRIX is not indicated for prevention of primary varicella infection (chickenpox)
  • SHINGRIX is supplied as 2 components: A single-dose vial of lyophilized gE antigen component (brown cap) and a single-dose vial of adjuvant suspension component (blue-green cap) (packaged without syringes or needles)
  • More …
Volume
1 Dose 10 Doses
  Log In to Order
or

Professionals Also Viewed


Product Specifications


McKesson #1080947
Manufacturer #58160081912
BrandShingrix®
ManufacturerGlaxo Smith Kline
Country of OriginUnknown
ApplicationShingles Vaccine
Container TypeSingle Dose Vial Kit
Dosage FormInjection
Generic Drug Code43989
Generic Drug NameZoster Vaccine Recombinant, Adjuvanted
NDC Number58160081912
Product DatingMcKesson Acceptable Dating: we will ship >= 180 days
Storage RequirementsRequires Refrigeration
Strength50 mcg / 0.5 mL
TypeIntramuscular
UNSPSC Code51201650
User50 Years of Age and Older
Volume1 Dose
Features
  • SHINGRIX is a vaccine indicated for prevention of herpes zoster (shingles) in adults aged 50 years and older
  • SHINGRIX is not indicated for prevention of primary varicella infection (chickenpox)
  • SHINGRIX is supplied as 2 components: A single-dose vial of lyophilized gE antigen component (brown cap) and a single-dose vial of adjuvant suspension component (blue-green cap) (packaged without syringes or needles)
  • A single dose after reconstitution is 0.5 mL
  • Administer 2 doses (0.5 mL each) at 0 and 2 to 6 months
More Information